Skip to main content
TipRanks
Go Ultimate75% OFF

Karyopharm Therapeutics (KPTI) Ownership - Who Owns Karyopharm Therapeutics?

3 Followers

Karyopharm Therapeutics (KPTI) Ownership Overview

  • 3.63% Insiders
  • 19.83% Mutual Funds
  • 8.88% Other Institutional Investors
  • 4.75% ETFs
  • 62.91% Public Companies and Individual Investors

The ownership structure of Karyopharm Therapeutics (CH:KPTI) stock is a mix of institutional, retail, and individual investors. Approximately 33.45% of the company’s stock is owned by Institutional Investors, 3.63% is owned by Insiders, and 62.91% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Recent Insider Trading Activity
DateNameActivityValue

Recent Hedge Fund Trading Activity

Recent Hedge Fund Trading Activity
DateFirmActivityValue

Top Shareholders

CH:KPTI top shareholders
Holder# of SharesType% HoldingValue
Peter Kolchinsky1,917,354Institution8.45%―
BlackRock, Inc.1,521,918Institution6.71%―
Mutual Fund Series Trust1,125,000Institution4.96%―
Vanguard1,076,752Institution4.75%―
Vanguard Index Funds940,813Institution4.15%―
Delaware Group Equity Funds Iv566,666Institution2.50%―
T. Rowe Price Small-cap Value Fund, Inc.435,070Institution1.92%―
Tiaa-cref Funds429,563Institution1.89%―
Richard A. Paulson269,747Insider1.19%―
Fidelity Salem Street Trust242,385Institution1.07%―

Top Mutual Fund Holders

CH:KPTI top mutual fund holders
Holder# of SharesType% HoldingValue
Mutual Fund Series Trust1,125,000Institution4.96%―
Vanguard Index Funds940,813Institution4.15%―
Delaware Group Equity Funds Iv566,666Institution2.50%―
T. Rowe Price Small-cap Value Fund, Inc.435,070Institution1.92%―
Tiaa-cref Funds429,563Institution1.89%―
Fidelity Salem Street Trust242,385Institution1.07%―
Fidelity Concord Street Trust184,450Institution0.81%―
Fidelity Commonwealth Trust Ii169,383Institution0.75%―
Vanguard Scottsdale Funds134,149Institution0.59%―
Bridgeway Funds, Inc.71,873Institution0.32%―

FAQ

Who Owns Karyopharm Therapeutics (CH:KPTI)?
According to the latest TipRanks data, approximately 33.45% of the company's stock is held by institutional investors, 3.63% is held by insiders, and 62.91% is held by public companies and individual investors.
What percentage of Karyopharm Therapeutics (CH:KPTI) stock is held by institutional investors?
According to the latest TipRanks data, approximately 33.45% of Karyopharm Therapeutics (CH:KPTI) stock is held by institutional investors: 19.83% by mutual funds, 4.75% by ETFs and 8.88% by other institutional investors.
What percentage of Karyopharm Therapeutics (CH:KPTI) stock is held by retail investors?
According to the latest TipRanks data, approximately 62.91% of Karyopharm Therapeutics (CH:KPTI) stock is held by public companies and individual investors.
Who owns the most shares of Karyopharm Therapeutics (CH:KPTI)?
Peter Kolchinsky owns the most shares of Karyopharm Therapeutics (CH:KPTI).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.